• Carolyn D Seib, Calyani Ganesan, Adam Furst, Alan C Pao, Glenn M Chertow, John T Leppert, Insoo Suh, Maria E Montez-Rath, HarrisAlex H SAHSStanford-Surgery Policy Improvement Research and Education Center (S-SPIRE), Department of Surgery, Stanford University School of Medicine, and Center for Innovation to Implementation, Veterans Affairs Palo Alto, Palo Alto, California (A., Amber W Trickey, Electron Kebebew, and Manjula Kurella Tamura.
• Stanford-Surgery Policy Improvement Research and Education Center (S-SPIRE), Department of Surgery, Stanford University School of Medicine; Division of General Surgery, Palo Alto Veterans Affairs Health Care System; and Geriatric Research, Education and Clinical Center, Veterans Affairs Palo Alto, Palo Alto, California (C.D.S.).
• Ann. Intern. Med. 2023 May 1; 176 (5): 624631624-631.

BackgroundMultidisciplinary guidelines recommend parathyroidectomy to slow the progression of chronic kidney disease in patients with primary hyperparathyroidism (PHPT) and an estimated glomerular filtration rate (eGFR) less than 60 mL/min/1.73 m2. Limited data address the effect of parathyroidectomy on long-term kidney function.ObjectiveTo compare the incidence of a sustained decline in eGFR of at least 50% among patients with PHPT treated with parathyroidectomy versus nonoperative management.DesignTarget trial emulation was done using observational data from adults with PHPT, using an extended Cox model with time-varying inverse probability weighting.SettingVeterans Health Administration.PatientsPatients with a new biochemical diagnosis of PHPT in 2000 to 2019.MeasurementsSustained decline of at least 50% from pretreatment eGFR.ResultsAmong 43 697 patients with PHPT (mean age, 66.8 years), 2928 (6.7%) had a decline of at least 50% in eGFR over a median follow-up of 4.9 years. The weighted cumulative incidence of eGFR decline was 5.1% at 5 years and 10.8% at 10 years in patients managed with parathyroidectomy, compared with 5.1% and 12.0%, respectively, in those managed nonoperatively. The adjusted hazard of eGFR decline did not differ between parathyroidectomy and nonoperative management (hazard ratio [HR], 0.98 [95% CI, 0.82 to 1.16]). Subgroup analyses found no heterogeneity of treatment effect based on pretreatment kidney function. Parathyroidectomy was associated with a reduced hazard of the primary outcome among patients younger than 60 years (HR, 0.75 [CI, 0.59 to 0.93]) that was not evident among those aged 60 years or older (HR, 1.08 [CI, 0.87 to 1.34]).LimitationAnalyses were done in a predominantly male cohort using observational data.ConclusionParathyroidectomy had no effect on long-term kidney function in older adults with PHPT. Potential benefits related to kidney function should not be the primary consideration for PHPT treatment decisions.Primary Funding SourceNational Institute on Aging.

27 keywords...

hide…